dermatology

Kaitlyn D’OnofrioPsoriasis | April 12, 2023
Early identification of certain patient factors may predict long-term outcomes in psoriasis, according to a study. ...
Read More
Kaitlyn D’OnofrioPsoriasis | April 12, 2023
A qualitative study explored the quality of life in patients living with psoriasis—as well as what the phrase means to ...
Kaitlyn D’OnofrioPsoriasis | April 12, 2023
Patients with psoriasis may achieve better outcomes with secukinumab compared to ustekinumab, according to a study. ...
Kaitlyn D’OnofrioPsoriasis | April 12, 2023
The results of two randomized clinical trials found that risankizumab was associated with improved symptoms, mental ...
Kaitlyn D’OnofrioInfectious Disease | April 12, 2023
Human IgG1κ monoclonal antibody secukinumab used to treat patients with psoriatic arthritis (PsA), psoriasis (PsO), and ...
Rob DillardSkin Cancer | April 12, 2023
Researchers have presented a new, quantitative technique that uses DNA sequencing to accurately predicts the recurrence ...
Kaitlyn D’OnofrioSkin Cancer | April 12, 2023
A second opinion from a dermatopathologist could improve reliability of melanocytic lesion diagnosis, according to a ...
Kaitlyn D’OnofrioPsoriasis | April 12, 2023
Pediatric psoriasis patients have a higher risk of other comorbidities—including psychiatric disorders—than their ...
DocWire News EditorsRheumatology | August 30, 2018
Antimalarials, particularly hydroxychloroquine, may be useful for cutaneous ...
Andrew ChoSkin Cancer | April 12, 2023
A study published in JAMA Dermatology investigated the prevalence of self-skin cancer examinations and professional skin ...
Advertisement
Advertisement
Latest News

February 23, 2024